Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Autoimmune Disorders

  Free Subscription


30.03.2026

1 Am J Kidney Dis
2 Ann Neurol
2 BMC Neurol
1 Brain
2 Intern Med
2 J Autoimmun
1 J Clin Endocrinol Metab
2 J Immunol
4 J Neurol
3 Kidney Int
1 Lancet Neurol
1 Mult Scler
1 PLoS Biol
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Kidney Dis

  1. POLLACK JS
    The Roller Coaster Ride of IgA Nephropathy.
    Am J Kidney Dis. 2026 Mar 26:S0272-6386(26)00041.
    PubMed        


    Ann Neurol

  2. WANG Y, Gao X, Kokubun N, Shan F, et al
    Gelsolin-3: A Novel Myelin Autoantigen in Demyelinating Guillain-Barre Syndrome.
    Ann Neurol. 2026 Mar 24. doi: 10.1002/ana.78198.
    PubMed         Abstract available

  3. THAKOLWIBOON S, Wood KN, Stabile A, Paramasivan N, et al
    Population-Based Epidemiology of Autoimmune Seizures and Epilepsies.
    Ann Neurol. 2026 Mar 24. doi: 10.1002/ana.78204.
    PubMed         Abstract available


    BMC Neurol

  4. SHEN Y, Wang J, Han Z, Shi W, et al
    Posterior reversible encephalopathy syndrome in the setting of severe systemic lupus erythematosus activity with a rapidly fatal outcome: a case report.
    BMC Neurol. 2026 Mar 25. doi: 10.1186/s12883-026-04771.
    PubMed        

  5. LUAN Z, Du M, Liang Z, Song F, et al
    Successful treatment of Anti-NF155 antibody positive autoimmune nodopathy with telitacicept: a case report.
    BMC Neurol. 2026 Mar 24. doi: 10.1186/s12883-026-04841.
    PubMed        


    Brain

  6. JACOBS BM, Vandebergh M, Maltby VE, Dobson R, et al
    Interplay between genetic and environmental risk factors in multiple sclerosis: what have we learned?
    Brain. 2026 Mar 27:awag111. doi: 10.1093.
    PubMed         Abstract available


    Intern Med

  7. YOSHIZUMI K, Watanabe S, Kimura T, Igeta M, et al
    Extrathymic malignancies in patients with myasthenia gravis: A Japanese multicenter study.
    Intern Med. 2026 Mar 24. doi: 10.2169/internalmedicine.7065.
    PubMed         Abstract available

  8. SUZUKI Y, Hayashi K, Sato T, Suzuki E, et al
    Hypereosinophilic Syndrome with Eosinophilic Myocarditis and Coexisting Autoimmune Hemolytic Anemia: A Case Report.
    Intern Med. 2026 Mar 24. doi: 10.2169/internalmedicine.6915.
    PubMed         Abstract available


    J Autoimmun

  9. CUI Z, Ooi JD, Ting YT
    TCR recognition of peptide-HLA class II complexes in autoimmunity: Structural insights for therapeutic targeting.
    J Autoimmun. 2026;160:103549.
    PubMed         Abstract available

  10. HARVEY GR, Ashur I, Bossuyt X, Bluethner M, et al
    Interlaboratory variability in laboratory testing and reporting of myositis autoantibodies.
    J Autoimmun. 2026;160:103548.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  11. SMITH AH, Priscu A, Morkos M
    Initial Disease Severity and Methimazole Titration for Graves' Disease: A Retrospective Longitudinal Cohort Study.
    J Clin Endocrinol Metab. 2026 Mar 26:dgag134. doi: 10.1210.
    PubMed         Abstract available


    J Immunol

  12. PREMACHANDRAN S, Groh AMR, Sinott A, Senthil S, et al
    Margins of control: ventricular brain borders as architects in central nervous system autoimmunity.
    J Immunol. 2026;215.
    PubMed         Abstract available

  13. CONWAY H, Bernard J, Ramos R, Zahran S, et al
    Altered B cell metabolic pathways characterize type 1 diabetes progression.
    J Immunol. 2025 Dec 27:vkaf330. doi: 10.1093.
    PubMed         Abstract available


    J Neurol

  14. YEH WZ, Francis A, Butzkueven H, Geraldes R, et al
    Prediction of relapse in myelin oligodendrocyte glycoprotein antibody-associated disease: external validation of the MOG-AR score.
    J Neurol. 2026;273:224.
    PubMed         Abstract available

  15. FALSO S, Spagni G, Monte G, Marini S, et al
    Half a century of change: demographic trends and their clinical impact in acetylcholine receptor antibody-positive myasthenia gravis.
    J Neurol. 2026;273:227.
    PubMed         Abstract available

  16. ANDERSEN LK, Birnbaum S, Missel M, Petersen KG, et al
    Assessing respiratory status in myasthenia gravis: limited value of the MG-ADL as a standalone tool compared with spirometry in a Danish cohort.
    J Neurol. 2026;273:231.
    PubMed         Abstract available

  17. MONTALBAN X, Hohlfeld R, Pozzilli C, Freedman MS, et al
    Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study.
    J Neurol. 2026;273:234.
    PubMed         Abstract available


    Kidney Int

  18. PERKINS GB, Naesens M
    Nobel prize-winning Treg cells in autoimmune kidney diseases and transplantation.
    Kidney Int. 2026;109:624-629.
    PubMed         Abstract available

  19. RIZK DV
    Predicting steroid treatment benefit in IgA nephropathy: are we ready for precision care?
    Kidney Int. 2026;109:649-651.
    PubMed         Abstract available

  20. COLOMBAT M, Dalloux-Chioccioli J, Bancal E, Mouton E, et al
    Laser microdissection coupled to mass spectrometry is more sensitive than immunohistochemistry in diagnosing phospholipase A2 receptor-positive membranous nephropathy.
    Kidney Int. 2026;109:796-797.
    PubMed        


    Lancet Neurol

  21. GUASP M, Simabukuro MM, Munoz-Sanchez G, Brenner J, et al
    Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort study.
    Lancet Neurol. 2026;25:368-378.
    PubMed         Abstract available


    Mult Scler

  22. MILLER DM, Li Y, Husak S, Abbatemarco J, et al
    Relationships between neighborhood deprivation, race, and worsening outcomes among MS patients 55 years of age and older.
    Mult Scler. 2026 Mar 23:13524585261423408. doi: 10.1177/13524585261423408.
    PubMed         Abstract available


    PLoS Biol

  23. LONG W, Endo A, Walakulu Gamage HN, Yang T, et al
    Disrupting CD22-cis-ligand interactions ameliorates type 1 diabetes and graft rejection by expanding regulatory B cells.
    PLoS Biol. 2026;24:e3003681.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  24. SANMARCO LM, Pellerin A, Green T, Plasencia A, et al
    Polypharmacology of S-1117, an Fc-fused IgG-selective degrading enzyme, for chronic treatment of autoantibody-mediated diseases.
    Proc Natl Acad Sci U S A. 2026;123:e2518366123.
    PubMed         Abstract available

  25. BARMAN S, Rauber S, Eisenhut K, Esser D, et al
    Immune cell profiling reveals expanded stem cell-like memory T cells in anti-GAD65-associated neurological syndromes.
    Proc Natl Acad Sci U S A. 2026;123:e2514753123.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum